Both Tirzepatide and Mounjaro represent new methods to managing type 2 diabetes, and increasingly, excess weight. It is a twin receptor activator that targets two chemicals involved in metabolism: this peptide and GIP. It, often seen as a brand name for this compound, acts similarly, offering sub